Healthcare
Live Price
Offline$612.14
+0.11% today
1Y Change
+20.09%
Window
Jun 20, 2025 โ Jun 12, 2026
Coverage: 246 bars ยท Jun 20, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Regeneron Pharmaceuticals, Inc. (REGN) is a Healthcare stock with a market cap of $72.26B and listed on NASDAQ. The stock last traded around $612.14 and up 20.1% across the available one-year price window (Jun 20, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of +1.0%, EPS growth of +5.3%, a dividend yield of 0.5%. What stands out right now is revenue +1.0%, EPS +5.3%, free cash flow +11.3% with operating margin 24.3% and ROIC 8.5%. The dividend is present but secondary, with a yield around 0.5%. Valuation is more restrained than many high-expectation growth names at P/E 16.5 and price/sales 4.8. Stock Foundry combines REGN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
REGN
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
REGN Max Drawdown
-26.05%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for REGN and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
0.51%
Trailing 12M Payout
$2.70
Last Payout
| Ex-Date | Record | Pay | Dividend | Adj | Frequency |
|---|---|---|---|---|---|
| Feb 20, 2026 | Feb 20, 2026 | Mar 5, 2026 | $0.94 | $0.94 | Quarterly |
| Nov 20, 2025 | Nov 20, 2025 | Dec 5, 2025 | $0.88 | $0.88 | Quarterly |
| Aug 18, 2025 | Aug 18, 2025 | Sep 3, 2025 | $0.88 | $0.88 | Quarterly |
| May 20, 2025 | May 20, 2025 | Jun 6, 2025 | $0.88 | $0.88 | Quarterly |
| Feb 20, 2025 | Feb 20, 2025 | Mar 20, 2025 | $0.88 | $0.88 | Quarterly |
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.